Results 81 to 90 of about 5,129,522 (237)

Ramalin Ameliorates Alzheimer's Disease Pathology by Targeting BACE1, HDAC6, and MAPK Pathways

open access: yesMedComm, Volume 7, Issue 1, January 2026.
Ramalin alleviates Alzheimer's disease pathology by selectively inhibiting HDAC6, reducing BACE1 levels, and suppressing neuroinflammation through downregulation of the NLRP3 inflammasome and iNOS. It restores synaptic function impaired by Aβ toxicity and improves cognitive performance in AD mouse models, APP/PS1 and 3xTg‐AD.
Yongeun Cho   +18 more
wiley   +1 more source

Chelation Therapy for Rare Earth Element Toxicity: Current Evidence, Challenges and Future Directions

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 138, Issue 1, January 2026.
ABSTRACT The accelerating integration of rare earth elements (REEs) in advanced technologies has generated rising concern over human exposure and the attendant toxicological risks. This review presents an up‐to‐date synthesis of current evidence on REE toxicity across multiple exposure pathways, including inhalation, ingestion and occupational contact,
Jose L. Domingo
wiley   +1 more source

Matrix Metalloproteinase Inhibition in Melanoma

open access: yesExperimental Dermatology, Volume 35, Issue 1, January 2026.
ABSTRACT Matrix metalloproteinases (MMPs) are involved in the degradation of the extracellular matrix (ECM) and are found to participate in all stages of tumour progression including modifying signalling pathways, regulating cytokines and promoting tumour growth, particularly by inducing angiogenesis and facilitating cancer spread.
Ellie Zhang   +2 more
wiley   +1 more source

Rational Design of Novel Inhibitors: Integrating 3D‐QSAR and Molecular Dynamics

open access: yesBioMed Research International, Volume 2026, Issue 1, 2026.
This study presents an integrated computational framework that combines three‐dimensional quantitative structure–activity relationship (3D‐QSAR) modeling with molecular dynamics (MD) simulations to advance the rational design of triazole‐based urease inhibitors.
Neda Shakour   +4 more
wiley   +1 more source

Pharmacological Effects of Anthranilic Hydroxamic Acid and Certain Other Hydroxamic Acids

open access: yesExperimental Biology and Medicine, 1960
SummaryThe hydroxamate of anthranilic acid injected intraperitoneally into rats in a dose of 1.0 mg/g causes anesthesia lasting 10 hours or more. Recovery is apparently complete. One half this dose causes tranquilization and suppression of the conditioned avoidance response. The compound protects mice against twice the lethal dose of strychnine.
F. Bernheim, J. K. Stoops
openaire   +1 more source

Nucleic acid binding affinity and antioxidant activity of N-m-Tolyl-4-Chlorophenoxyacetohydroxamicacid

open access: yesScientific Reports
Hydroxamic acids represent a group of weak organic acids, both naturally occurring and synthetically derived, characterized by the general formula RC(= O)N(R’OH).
Rubi Khilari   +8 more
doaj   +1 more source

Crystal structure of N-hydroxypicolinamide monohydrate

open access: yesActa Crystallographica Section E: Crystallographic Communications, 2016
The crystal structure of the title compound, C6H6N2O2·H2O, consists of N-hydroxypicolinamide and water molecules connected through O—H...O and N—H...N hydrogen bonds.
Inna S. Safyanova   +2 more
doaj   +1 more source

The Analytical Applications And Biological Activity of Hydroxamic acids

open access: yes, 2014
Hydroxamic acids play a vital role in applied chemistry , the present literature review is an investigation on the analytical applications and biological activity of hydroxamic acids .
M. Abualreish   +1 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy